Page last updated: 2024-11-07

dextroamphetamine and Acute Confusional Senile Dementia

dextroamphetamine has been researched along with Acute Confusional Senile Dementia in 4 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lanctôt, KL2
Herrmann, N2
Black, SE2
Ryan, M2
Rothenburg, LS2
Liu, BA2
Busto, UE2
Ksir, C1
Benson, DM1
Martinez, R1
Molchan, SE1
Lawlor, BA1
Thompson, K1
Martinson, H1
Latham, G1
Weingartner, H1
Sunderland, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Role of the Dopaminergic Brain Reward System in Apathy Associated With Alzheimer's Disease[NCT00254033]Phase 440 participants Interventional2003-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for dextroamphetamine and Acute Confusional Senile Dementia

ArticleYear
Apathy associated with Alzheimer disease: use of dextroamphetamine challenge.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2008, Volume: 16, Issue:7

    Topics: Aged; Alzheimer Disease; Analysis of Variance; Behavioral Symptoms; Dextroamphetamine; Dopamine; Dop

2008
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Attention; Brain; Central Nervous System Stimulants; Cro

2008
Minimal effects of dextroamphetamine on scopolamine-induced cognitive impairments in humans.
    Biological psychiatry, 1997, Jan-01, Volume: 41, Issue:1

    Topics: Adult; Alzheimer Disease; Attention; Central Nervous System Stimulants; Cognition; Dextroamphetamine

1997

Other Studies

1 other study available for dextroamphetamine and Acute Confusional Senile Dementia

ArticleYear
Enhanced behavioral response to nicotine in an animal model of Alzheimer's disease.
    Psychopharmacology, 1983, Volume: 81, Issue:3

    Topics: Alzheimer Disease; Animals; Dextroamphetamine; Disease Models, Animal; Humans; Kainic Acid; Male; Mo

1983